Contact
Please use this form to send email to PR contact of this press release:
YMAB FINAL DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Y-mAbs Therapeutics (YMAB) Investors with Significant Losses to Contact Firm's Attorneys Before Mar. 20th Deadline in Securities Fraud Class Action
TO: